1 / 12

METHODS TO STUDY DRUG SAFETY PROBLEMS

animal experiments clinical trials epidemiological methods spontaneous reporting case reports case series. Post-Marketing Surveillance (PMS) prescription event monitoring cohort studies intensive hospital monitoring case - control studies record-linkage meta -analysis.

rich
Télécharger la présentation

METHODS TO STUDY DRUG SAFETY PROBLEMS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. animal experiments clinical trials epidemiological methods spontaneous reporting case reports case series Post-Marketing Surveillance (PMS) prescription event monitoring cohort studies intensive hospital monitoring case - control studies record-linkage meta-analysis METHODS TO STUDY DRUG SAFETY PROBLEMS

  2. Spontaneous reporting Principle The alert health professional connects an undesirable medical event with drug exposure (SUSPICION) Reports suspicion to information collecting centre

  3. ADVERSE DRUG REACTION • A reaction which is noxious and unintended, and which occurs at doses normally used in man for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological function WHO definition

  4. ADVERSE EVENT/EXPERIENCE • Any untoward medical occurrence that may present during treatment with a pharmaceutical product but which does not necessarily have a causal relationship with this treatment WHO definition

  5. SPONTANEOUS REPORTING • Advantages • large population • all medicines • hospital and out-patient care • long perspective • patient analyses possible • inexpensive

  6. SPONTANEOUS REPORTING • Disadvantages • underreporting

  7. Reporting varies with: • severity of reaction • time from market introduction • promotional claims • promotion of reporting system • publicity of specific association

  8. SPONTANEOUS REPORTING • Disadvantages • difficult to detect • delayed reactions • reactions with high background incidence • important details often missing • number of exposed unknown • bias • underreporting

  9. When to report?Early phase • Simple message : • Report as soon as you suspect that drug therapy has resulted in a negative, unintended effect. • i.e all suspected reactions • Speed is essential

  10. What to report? • Adverse reactions • Type A • Type B • Lack of effect • counterfeiting • resistance • interaction • Quality problem • Dependence and abuse • Poisoning (?) • Medical error (?)

  11. What to report? • Allopathic medicines • Prescription • OTC • Traditional medicines • Biologicals incl vaccines

  12. What to report?Alternative approach • Serious reactions (definitions available) • Unexpected reaction (not in product info) • Unusually severe reactions • New medicines

More Related